Limitations of Stem Cell Therapy for Parkinson’s Disease
Zhuowei Li, Shijun Peng, Jia Ouyang, Ruen Liu · 2026
Read Limitations of Stem Cell Therapy for Parkinson’s Disease by Zhuowei Li, Shijun Peng, Jia Ouyang, Ruen Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13162666.txt.
Description
Zhuowei Li and three co-authors review the limits of stem cell therapy for Parkinson's disease, in this 2026 article. Replacing the brain cells lost to Parkinson's with lab-grown ones has reached many clinical trials. Results have swung widely between studies and patients. The authors sort the shortfalls into three families: the disease process itself, the symptoms treated, and the patients eligible.
Stem cells mainly address movement symptoms driven by dopamine loss. They do little for the many non-movement problems, from sleep trouble to dementia, and they do not stop the underlying disease from spreading to new cells. Some patient groups are poor candidates altogether. The review looks at rescue strategies, especially pairing cell therapy with gene therapy and other new tools, to cover those gaps. It is a sober map of what cell replacement can and cannot promise.
Catalog record
| CREATOR | Zhuowei Li, Shijun Peng, Jia Ouyang, Ruen Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |